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A B S T R A C T  
Objective: To determine the prevalence of Vitamin-D deficiency and insufficiency in patients complaining of arthralgia. 
Patients and Methods: This cross-sectional study included a group of 332 individuals complaining of arthralgia, 
selected by consecutive sampling technique. Vitamin-D blood level was performed by ELISA method. Data were entered 
and analyzed using SPSS Software (Version 15). Mean and Standard deviation was calculated for Quantitative variables 
and frequency with percentage was presented for Qualitative variables. Chi-Square test was applied to assess any 
association between Qualitative variables. P value less than 0.05 was considered significant. 
Results: Out of 332 individuals who had arthralgia, 9.03% (30).12% (17) and 85.84% (285) had Vitamin-D sufficiency, 
insufficiency and deficiency. Among total sample population, 75.0% (249) were females and 25.0% (83) were males. In 
females 8.83% (22), 6.02% (15) and 85.1% (212) had Vitamin-D sufficiency, insufficiency and deficiency (p-value 0.430). 
Out of 212 Vitamin-D deficient females,48.5% (103), 16.98% (36) and 34.4% (73) had severe, moderate and mild 
Vitamin-D deficiency(p-value=0.844). In male patients 9.63% (8),2.40% (2) and 87.95% (73) of males had Vitamin-D 
sufficiency, insufficiency and deficiency (p-value=0.430). Out of 73 Vitamin-D deficient males, 45.20%(33) ,16.43% (12) 
and 38.3% (28) had severe moderate and mild Vitamin-D deficiency(p-value=0.844). In females Vitamin-D deficiency 
was found to be most prevalent in age groups of 41-60 years. Whereas in males Vitamin-D deficiency was found to be 
most prevalent in age groups of 31-40years. 
Conclusion: Vitamin D deficiency/insufficiency is an important factor leading to arthralgia, keeping the prevalence rate 
of about 90% in mind. 
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I n t r o d u c t i o n  
 
Vitamin D commonly called the “Sunshine Vitamin” is 
synthesized in the body when the skin is exposed to 
sunlight directly, making it unique amongst others. It is a 
fat-soluble vitamin and is commonly stored in the body’s 
fatty tissue.1 Vitamin D3, is essential for maintaining 
mineral homeostasis and normal skeletal architecture. 
Vitamin D and its synthetic analogues also have 
antiproliferative, prodifferentiative, and immunomodulatory 
activities. Vitamin D3 has physiological and 
pharmacological actions in various systems, after the 
recognition of Vitamin D receptors (VDR) in target cells. 
There are potential therapeutic applications of VDR 
ligands in inflammation like dermatological indications, 
osteoporosis, cancers, secondary hyperparathyroidism, 
and autoimmune diseases.2-11 Vitamin D3 circulating 
levels greater than 75 nmol/L, or 30 ng/mL, is beneficially 
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required for good health, at least 800–1000 IU vitamin D3 
may be required for maintaining good health. Vitamin D2 
when given in physiological concentrations may be 
equally effective for maintaining circulating concentrations 
of 25-hydroxyvitamin.12-17 Exposure to sunlight is the major 
source of vitamin D for most humans. Vitamin D is 
naturally present in oily fish like salmon and mackerel and 
oils from fish, including cod liver oil. Dairy products like 
cheese, butter, cream also contain Vitamin D. In 
developed countries fortification of milk products, juice 
products, breads, yogurts, and cheeses is done with 
vitamin D.18, 19 Vitamin D deficiency is recognized as a 
pandemic. It causes rickets in children and osteopenia, 
osteomalacia, osteoporosis, and fractures in adults.30  
Research has linked Vitamin D deficiency with increased 
risk of common cancers, autoimmune diseases, 
hypertension, and infectious diseases.19-27 Inadequate 
nutritional intake of vitamin D along with inadequate 
sunlight, faulty vitamin D absorption, and failure of 
converting vitamin D into active form results in Vitamin D3 
deficiency.28-32 Serum Vitamin D3 concentration is the 
most reliable marker of vitamin D status.12 Vitamin D 
deficiency is increasing day by day worldwide affecting 
individuals of all age groups. Global awareness about 
vitamin D benefits and its deficiency is still seriously 
lacking. People with Vitamin D deficiency may develop a 
feeling of being sleepy, lethargic, lazy, and tired along 
with body aches and muscle cramps. In addition to these 
signs the development and growth of body in infants and 
children may be affected, with delay in tooth formation 
and breathing difficulty.28-32 
P a t i e n t s  a n d  M e t h o d s  
This cross-sectional study was conducted at Social 
Security Hospital Islamabad from 20-April-2011 to 20-
April 2012. Sample size was calculated by using WHO 
Sample size calculator taking confidence level of 95%, 
anticipated population proportion 70% and absolute 
precision 5%.11   Sample size turned out to be 323. Initially 
350 individuals were included to overcome the possibility 
of dropouts. Patients complaining of arthralgia with age 
range of 2-86 years were selected by consecutive non 
probability sampling. Voluntary informed written consent 
was taken by all the study subjects. Those individuals 
refused to give informed consent were excluded. The 
serum vitamin D3 levels were performed by ELISA. 
According to reference ranges, “Vitamin D3 
concentrations >30 ng/mL are considered to be sufficient. 
Vitamin D3 concentrations of 51–74 nmol/L, or 21–29 
ng/mL, indicate insufficiency. Whereas Vitamin D3 
concentration <50 nmol/L, or 20 ng/mL, is an indication of 
vitamin D deficiency”. Vitamin D3 deficiency is further 
classified into severe, moderate and mild deficiencies. 
According to definition “Vitamin D3 levels below 5ng/ml is 
considered as severe Vitamin D3 deficiency, Vitamin D3 
levels between 5-12ng/ml is considered moderate Vitamin 
D3 deficiency, whereas Vitamin D3 levels between 12-
20ng/ml is considered mild Vitamin D3 deficiency”.12 
Data was entered and analyzed using SPSS Software 
(Version 15). Mean and Standard deviation was 
calculated for quantitative variables and frequency with 
percentage was presented for qualitative variables. Chi-
Square test or Fischer exact tests was applied, to assess 
any association between qualitative variables. p-value 
less than 0.05 was considered statistically significant.  
R e s u l t s  
Out of 332 participants, 83 were male and 249 were 
female. Male female ratio was 1:3. Among all patients 
suffering from arthralgia, 85.84% had Vitamin D3 
deficiency, 5.12% individuals had an insufficient levels 
and only 9.03% individuals had a sufficient Vitamin D3 
levels (Figure 1).  
 
Figure 1: Vitamin D levels among study participants 
(n=332) 
Gender wise distribution shows that (73) 87.95% of male 
and (212) 85.1% of female patients had Vitamin D3 
deficiency.  Among them, 45.20% males and 48.5% 
females had severe Vitamin D3 deficiency.  Sufficient 
levels of vitamin D were found only in 9.63% males and 
8.83% females (Table 1).   
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Figure 2: Vitamin D Deficiency in various Age Groups in 
Females and Male Patients. 
Figure 2 showed significant association (p=0.000) of 
vitamin D deficiency levels in different age groups among 
females as compared to males. Among females Vitamin-
D deficiency was found to be most prevalent in age 
groups of 41-60 years. Whereas in males Vitamin-D 
deficiency was found to be most prevalent in age groups 
of 31-40 years.  
D i s c u s s i o n  
Vitamin D deficiency is one the most common medical 
condition worldwide. According to an estimation, about 
one billion people in the world have vitamin D deficiency 
or insufficiency.19 Vitamin D deficiency has a high 
prevalence in Asian countries.36-39   A majority (90%) of 
Islamabad and Rawalpindi patients in this study were 
vitamin D deficient or insufficient. It is a matter of concern 
to see so much of Vitamin D deficiency in a country with 
ample sunshine. Increased pigmentation due to which 
more prolonged exposure to sun is required, inadequate 
dietary intake of Vitamin D, use of sun block, and Veil 
(purdah) observation, failure of conversion of Vitamin D 
into its active form in kidney, mal-absorption diseases and 
obesity may be responsible for Vitamin D deficiency. 38 
Women are more likely to have vitamin D-deficiency than 
men.40 The use of veil in most women or clothing habits 
like wearing scarf and full sleeves clothes as a religious or 
cultural tradition limits sunlight exposure which may be a 
main reason for increased prevalence of vitamin D3 
deficiency in females as compared to males.37 People 
also use anti-solar (sun blocks) creams on the exposed 
area to prevent tanning. Apartments living is increasing 
day by day due to increase in population of the country 
and tendency to live in big cities are among other factors 
which restrict exposure to sun. 
Table:1 Vitamin D Levels 
 Gender of Patients Total P-Value 
Male Female 
Vit D 
Deficiency 
73(87.95%) 212(85.1%) 285(85.84%) 0.430 
Vit D 
Insufficiency 
2(2.40%) 15(6.02%) 17(5.12%) 
Vit D 
Sufficiency 
8(9.63%) 22(8.83%) 30(9.03%) 
Total 83(25%) 249(75%) 332(100%) 
Severe 
Deficiency 
33(45.20%) 103(48.5%) 136(47.7%) 0.844 
Mild Deficiency 28(38.3%) 73(34.4%) 101(35.43%) 
Moderate 
Deficiency 
12(16.43%) 36(16.98%) 48(16.84%) 
Total 73(25.61%) 212(74.38%) 285(100%) 
In females, Vitamin D3 deficiency is most prevalent in age 
groups of 41-60 years, which depicts that Vitamin D3 
deficiency in females is common in middle and old age 
group. The reason for Increased Vitamin D deficiency in 
middle age group may be that usually requirement 
exceeds the intake of Vitamin D in reproductive and 
lactation period in life of women. Whereas in females of 
old age or post-menopausal women there is a marked 
decrease in oestrogen levels which may be a factor 
leading to Vitamin D deficiency in them. In males, Vitamin 
D3 deficiency is most prevalent in age groups of 31-40 
years; however, there is no strong evidence based on 
previous research, which proves the actual cause of 
Vitamin D deficiency in a certain age group in male and 
female. 
Certain factors like clothing style, air pollution, skin 
pigmentation, insufficient vitamin D intake, lack of routine 
fortification of foods with vitamin D in Pakistan, could be 
the main factors responsible for such high rate of vitamin 
D deficiency in our population. The limitation of our study 
was that we did not include the type of diet, use of food 
containing vitamin D, duration of exposure to sunlight, and 
other possible risk factors for vitamin D deficiency. In 
order to prevent Vitamin D deficiency 10 to 15 minutes of 
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sunshine, three times a week (between 10am to 3pm), is 
recommended which will produce sufficient Vitamin D 
required for normal functioning of the body.38 People who 
do not live in sunny places may not make enough vitamin 
D through sun light, must fulfil their body Vitamin D 
requirements by diet. Vitamin D is found in dairy products 
like cheese, butter, cream and fortified milk. Fatty fish 
(such as tuna, salmon, and mackerel), Fortified breakfast 
cereals, margarine, and soy milk are also a rich source of 
Vitamin D.38,39 In case of severe deficiency Vitamin D 
supplementation is required. Depending upon age, 
situation and severity of the deficiency the doctor will 
prescribe the correct dosage of Vitamin D, which will be 
given as a medicine in syrup or tablets form, or in 
injectable form during severe deficiency.39-41. 
C o n c l u s i o n  
Vitamin D3 Deficiency and Insufficiency is Prevalent in 
above 90 % of Islamabad and Rawalpindi population 
presenting to physicians with arthralgia. So patients 
suffering from arthralgia or aches and pains should be 
checked for Vitamin D levels initially and may be given a 
symptomatic treatment for vitamin D3 deficiency. 
R e c o m m e n d a t i o n s  
Based on the findings of the study, we recommend 
fortification of food with vitamin D3 and adequate 
exposure to sunlight to prevent vitamin D deficiency and 
assessment of vitamin D status in routine, especially 
those with complaint of pains and aches. 
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